User profiles for "author:Erik Jørgensen"

Erik Jørgensen

Chief scientist. Department of Animal Science, Aarhus University
Verified email at agrsci.dk
Cited by 2885

Diagnosing diagnostic tests: evaluating the assumptions underlying the estimation of sensitivity and specificity in the absence of a gold standard

N Toft, E Jørgensen, S Højsgaard - Preventive veterinary medicine, 2005 - Elsevier
Latent class analysis to assess the sensitivity and specificity of a diagnostic test can be
carried out under different assumptions. An often applied set of assumptions is known as the …

Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

S Silber, P Albertsson, FF Avilés… - European heart …, 2005 - academic.oup.com
In patients with stable CAD, PCI can be considered a valuable initial mode of
revascularization in all patients with objective large ischaemia in the presence of almost …

Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design

AA Qayyum, M Haack-Sørensen… - Regenerative …, 2012 - Future Medicine
Adipose tissue represents an abundant, accessible source of multipotent adipose-derived
stromal cells (ADSCs). Animal studies have suggested that ADSCs have the potential to …

Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events

L Jespersen, A Hvelplund, SZ Abildstrøm… - European heart …, 2012 - academic.oup.com
Aims Patients with chest pain and no obstructive coronary artery disease (CAD) are
considered at low risk for cardiovascular events but evidence supporting this is scarce. We …

Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

D Erlinge, A Maehara, O Ben-Yehuda, HE Bøtker… - The Lancet, 2021 - thelancet.com
Background Near-infrared spectroscopy (NIRS) and intravascular ultrasound are promising
imaging modalities to identify non-obstructive plaques likely to cause coronary-related …

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

J Lønborg, N Vejlstrup, H Kelbæk… - European heart …, 2012 - academic.oup.com
Aims Exenatide, a glucagon-like-peptide-1 analogue, increases myocardial salvage in
experimental settings with coronary occlusion and subsequent reperfusion. We evaluated …

Direct intramyocardial plasmid vascular endothelial growth factor-A165gene therapy in patients with stable severe angina pectoris: A randomized double-blind …

J Kastrup, E Jørgensen, A Rück, K Tägil… - Journal of the American …, 2005 - jacc.org
Objectives: In the Euroinject One phase II randomized double-blind trial, therapeutic
angiogenesis of percutaneous intramyocardial plasmid gene transfer of vascular endothelial …

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3 …

T Engstrøm, H Kelbæk, S Helqvist, DE Høfsten… - The Lancet, 2015 - thelancet.com
Background Patients with acute ST-segment elevation myocardial infarction (STEMI) and
multivessel coronary disease have a worse prognosis compared with individuals with single …

Short-and long-term cause of death in patients treated with primary PCI for STEMI

F Pedersen, V Butrymovich, H Kelbæk… - Journal of the American …, 2014 - jacc.org
Background: Short-term mortality has been studied thoroughly in patients undergoing
primary percutaneous coronary intervention (PCI), whereas long-term cause of death in …

Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction …

RS Ripa, E Jørgensen, Y Wang, JJ Thune, JC Nilsson… - Circulation, 2006 - Am Heart Assoc
Background—Phase 1 clinical trials of granulocyte-colony stimulating factor (G-CSF)
treatment after myocardial infarction have indicated that G-CSF treatment is safe and may …